South Korea blood glucose monitoring devices market size reached US$ 213.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 482.13 Million by 2032, exhibiting a growth rate (CAGR) of 8.40% during 2024-2032. The growing focus on health and wellness, increasing awareness about the importance of diabetes management and early disease detection, and easy availability of health insurance policies represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023 |
Forecast Years
|
2024-2032 |
Historical Years
|
2018-2023
|
Market Size in 2023 | US$ 213.4 Million |
Market Forecast in 2032 | US$ 482.13 Million |
Market Growth Rate (2024-2032) | 8.40% |
Blood glucose monitoring devices, also known as blood glucose meters or glucometers, are essential tools that play a vital role in monitoring and managing blood glucose levels in individuals with diabetes. They comprise a meter and lancets for obtaining a blood sample, and test strips for analyzing the blood sample. They are user-friendly and portable and allow individuals to maintain improved control over their health. They help in detecting both low and high blood sugar levels while reducing the risk of severe complications. They enable patients and healthcare professionals to make informed decisions about insulin dosage, diet, and lifestyle adjustments. They offer enhanced convenience that encourages patients to monitor their blood sugar regularly, leading to improved adherence to monitoring routines. Besides this, they assist in reducing the frequency of hospital visits and the need for emergency care. As they aid in improving the quality of life of individuals suffering from diabetes and preventing or delaying diabetes-related complications, such as cardiovascular diseases, kidney problems, and neuropathy, the demand for blood glucose monitoring devices is rising in South Korea.
At present, increasing preferences for modern blood glucose monitoring devices that allow data sharing with healthcare providers and family members represent one of the major factors influencing the market positively in South Korea. Additionally, the rising adoption of blood glucose monitoring devices among the geriatric population, as they are more prone to diabetes, is impelling the market growth in the country. Besides this, the growing demand for blood glucose monitoring devices on account of the increasing prevalence of diabetes among the masses is offering a positive market outlook. Moreover, the rising adoption of blood glucose monitoring devices with remote monitoring capabilities, which facilitate timely interventions, is strengthening the market growth. In line with this, the increasing awareness about the importance of diabetes management among people is offering lucrative growth opportunities to industry investors operating in South Korea. Furthermore, there is a rise in the demand for cost-effective and easy-to-use blood glucose monitoring machines. This, coupled with the increasing focus on overall health and wellness, is contributing to the growth of the market in the country. Apart from this, the rising development of smart glucose meters and continuous glucose monitoring (CGM) systems for improved patient outcomes and satisfaction is bolstering the market growth. In addition, the wide availability of health insurance policies in the country is propelling the market growth.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on type.
Type Insights:
The report has provided a detailed breakup and analysis of the market based on the type. This includes self-monitoring blood glucose devices (glucometer devices, test strips, and lancets) and continuous blood glucose monitoring devices [sensors and durables (receivers and transmitters)].
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), and others.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Million |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Types Covered |
|
Regions Covered | Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), Others |
Companies Covered | Abbott Korea Co. Ltd., Arkray Inc., Ascensia Diabetes Care Korea Ltd., Dexcom Inc., etc. (Please note that this is only a partial list of the key players, and the complete list is provided in the report.) |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |